Scotland · NHS Scotland MSAN
Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials
MSAN(2024)23 · Level 2 · issued 13 May 2024
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Humalog® (insulin lispro) 100units/ml 10ml vials are out of stock with an estimated resupply | Out of stock | — |
| 2. NovoRapid® and Trurapi® (insulin aspart) 100units/ml 10ml vials remain available. | Available | — |
| 3. Admelog® and Lyumjev® (insulin lispro) 100units/ml 10ml vials remain available, however | Available | — |
| cannot support an increase in demand. | Available — cannot support uplift | — |
| 4. Fiasp® (insulin aspart) 100units/ml 10ml vials remain available, however cannot support an | Available — cannot support uplift | — |
| 3ml pre-filled pens remain available and can support increased demand. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.